All

Results: 34681-34692 of 77773

Hansa Biopharma data at the 2025 PNS Annual Meeting demonstrates potential of imlifidase in the treatment of GBS

GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)

Gentoo Media Inc. publishes Q1 2025 Interim Report: Strategic initiatives lay foundation for long-term growth

Maxon Introduces New Real-Time Rendering and Cinematic Previews Solution for Architects

Business Wire embedded0

Reply Presents “App to the Future”: A New AI-Scape Room Experience Powered by Microsoft AI and Low-Code Solutions

"Tea for Harmony - Yaji Cultural Salon" and "Jiangxi Day" Promotion Event Held in Morocco

BlueNord Announces First Quarter 2025 Results: Tyra Production Ramp-Up Continues and Second Distribution to Shareholders Proposed

PR Newswire associated0

International Training Course on Museum Management Concludes Successfully in Hangzhou

PR Newswire associated0

Cronofy secures £15m BGF investment to supercharge growth

More Uncertain Times Driving Positive Vibe for Insurance

PR Newswire associated0

Celebrating Sustainability Excellence across China - 2025 Sustainability & Innovation Awards winners announced in Shanghai

PR Newswire associated0

DAHON-V Speed Tech Created Buzz at CHINA CYCLE 2025!